Revexepride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRevexepride
Drug Alias Name瑞司必利revexeprida瑞维必利revexepridumM-0003 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksN/A